MME and breast carcinoma: A number of clinical trials are being conducted to investigate the therapeutic potential of targeting breast cancers with epigenetic-modifying drugs.47, 48, 49, 50 Our studies implicate NEP as an additional genetic target of AZA treatment that would suppress breast cancer invasion.